Related Experiment Video
Updated: Mar 1, 2026
16:26
Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
Published on: June 28, 2014
43.4K
Blood-brain barrier peptide shuttles.
Macarena Sánchez-Navarro1, Ernest Giralt2, Meritxell Teixidó1
1Institute for Research in Biomedicine-Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028 Barcelona, Spain.
Current Opinion in Chemical Biology
|May 31, 2017
Summary
Peptide shuttles offer a promising strategy to overcome the blood-brain barrier (BBB), enhancing drug delivery for treating brain diseases. This analysis reviews recent advancements in BBB peptide shuttle technology for improved therapeutic access.
Area of Science:
- Neuroscience
- Pharmacology
- Biotechnology
Background:
- The blood-brain barrier (BBB) restricts the passage of most molecules into the brain, posing a significant challenge for treating neurological disorders.
- The BBB possesses specific transport mechanisms that can be exploited for targeted drug delivery.
- Developing effective strategies to bypass or utilize the BBB is crucial for advancing brain therapeutics.
Purpose of the Study:
- To review and analyze the latest advancements in blood-brain barrier (BBB) peptide shuttles.
- To highlight the potential of BBB peptide shuttles in improving therapeutic delivery across the BBB.
- To provide an overview of current research trends and future directions in this field.
Main Methods:
- Literature review of recent scientific publications on BBB peptide shuttles.
- Analysis of studies focusing on the design, engineering, and application of peptide shuttles.
- Synthesis of information on mechanisms of BBB transport and therapeutic delivery.
Main Results:
- Peptide shuttles demonstrate significant potential for targeted drug delivery across the BBB.
- Various peptide sequences and engineering strategies have been developed to enhance BBB penetration.
- Successful examples of therapeutic cargo delivery using peptide shuttles are emerging.
Conclusions:
- BBB peptide shuttles represent a rapidly advancing and promising approach for brain drug delivery.
- Further research and development are needed to optimize peptide shuttle efficacy and safety for clinical applications.
- This technology holds great potential for treating a wide range of brain-related diseases.
Related Concept Videos
00:49The Blood-brain Barrier
54.1K
Overview
54.1K
01:25Physiological Barriers
5.4K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.4K
01:23Factors Affecting Drug Distribution: Physiological Barriers
853
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
853
01:23Transcellular Transport of Solutes
4.9K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
4.9K
01:06Carrier-Mediated Transport
1.4K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.4K
01:17Pore Transport and Ion-Pair Transport
1.5K
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
1.5K